作者：
Volpari, T. [1]
;
De Santis, F. [2]
;
Bracken, A. P. [3]
;
Pupa, S. M. [4]
;
Buschbeck, M. [5]
;
Wegner, A. [6]
;
Di Cosimo, S. [7]
;
Lisanti, Mp. [8]
;
Dotti, G. [9]
;
Massaia, M. [10]
;
Pruneri, G. [11]
;
Anichini, A. [12]
;
Fortunato, O. [13]
;
De Braud, F. ;
Del Vecchio, M. ;
Di Nicola, M.
作者单位：
Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Immunotherapy & Innovat Therapeut Unit, Milan, Italy
[1]
Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland
[2]
Fdn IRCCS Ist Nazl Tumori, Dept Appl Res & Technol Dev, Milan, Italy
[3]
Fdn IRCCS Ist Nazl Tumori, Dept Res, Tumor Genom Unit, Milan, Italy
[4]
Fdn IRCCS Ist Nazl Tumori, Dept Pathol & Lab Med, Milan, Italy
[5]
Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol & Hematol, Med Oncol Unit, Milan, Italy
[6]
Fdn IRCCS Ist Nazl Tumori, Dept Res, Mol Targeting Unit, Milan, Italy
[7]
Univ Autonoma Barcelona, Josep Carreras Leukemia Res Inst IJC, Campus ICO Germans Trias & Pujol
[8]
Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[9]
Fdn IRCCS Ist Nazl Tumori, Dept Res, Milan, Italy
[10]
Univ Torino, Ctr Interdipartimentale Ric Biol Mol, Lab Immunol Tumori Sangue, Turin, Italy
[11]
Univ Salford, Sch Environm & Life Sci, Translat Med, Biomed Res Ctr, Manchester, Lancs, England
[12]
Tech Univ Carolo Wilhelmina Braunschweig, Dept Bioinfomat & Biochem, Rebenring 56, D-38106
[13]
发布时间
2020-06-03
换一批
换一批
